AU2003290012A1 - L2-peptide of the human papillomavirus associated with virus-like particles - Google Patents
L2-peptide of the human papillomavirus associated with virus-like particlesInfo
- Publication number
- AU2003290012A1 AU2003290012A1 AU2003290012A AU2003290012A AU2003290012A1 AU 2003290012 A1 AU2003290012 A1 AU 2003290012A1 AU 2003290012 A AU2003290012 A AU 2003290012A AU 2003290012 A AU2003290012 A AU 2003290012A AU 2003290012 A1 AU2003290012 A1 AU 2003290012A1
- Authority
- AU
- Australia
- Prior art keywords
- virus
- peptide
- particles
- human papillomavirus
- papillomavirus associated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000701806 Human papillomavirus Species 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0228715A GB0228715D0 (en) | 2002-12-09 | 2002-12-09 | Vaccine |
GB0228715.9 | 2002-12-09 | ||
PCT/EP2003/014040 WO2004052395A1 (en) | 2002-12-09 | 2003-12-05 | L2-peptide of the human papillomavirus associated with virus-like particles |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003290012A1 true AU2003290012A1 (en) | 2004-06-30 |
Family
ID=9949366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003290012A Abandoned AU2003290012A1 (en) | 2002-12-09 | 2003-12-05 | L2-peptide of the human papillomavirus associated with virus-like particles |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003290012A1 (en) |
GB (1) | GB0228715D0 (en) |
WO (1) | WO2004052395A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006236905B2 (en) | 2005-04-15 | 2010-06-03 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen |
US8426163B2 (en) | 2007-12-07 | 2013-04-23 | National Health Research Institutes | Production of lipidated proteins in E. coli |
US8466259B2 (en) | 2007-12-07 | 2013-06-18 | National Health Research Institutes | Adjuvants |
US8287880B2 (en) | 2009-06-02 | 2012-10-16 | National Health Research Institutes | Lipidated vaccine against dengue virus infection |
WO2010148496A1 (en) | 2009-06-22 | 2010-12-29 | National Health Research Institutes | Lipidated tumor- associated antigens and immunotherapeutic compositions |
CN102497880A (en) | 2009-06-25 | 2012-06-13 | 葛兰素史密丝克莱恩生物有限公司 | Novel human papillomavirus (HPV) protein constructs and their use in the prevention of HPV disease |
US9717783B2 (en) | 2010-02-09 | 2017-08-01 | Stc.Unm | Immunogenic HPV L2-containing VLPs and related compositions, constructs, and therapeutic methods |
TWI507413B (en) * | 2010-11-15 | 2015-11-11 | Nat Health Research Institutes | Lipidated polyepitope vaccines |
TW201221642A (en) | 2010-11-15 | 2012-06-01 | Nat Health Research Institutes | Method of producing lipidated polypeptides |
MA40824A (en) | 2014-10-22 | 2017-08-29 | Saiba Gmbh | MODIFIED VIRUS TYPE CMV PARTICLES |
CN108025050B (en) * | 2015-09-08 | 2022-12-20 | 苏黎世大学 | Treatment of insect bite hypersensitivity |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618536A (en) * | 1992-09-03 | 1997-04-08 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric papillomavirus-like particles |
FR2749323B1 (en) * | 1996-06-04 | 1998-07-10 | Pasteur Merieux Serums Vacc | PSEUDO-PARTICLES VIRALES USEFUL AS A VECTOR OF NUCLEIC ACID DELIVERY |
GB9806666D0 (en) * | 1998-03-27 | 1998-05-27 | Stanley Margaret | Antigen preparation and use |
PT1506222E (en) * | 2002-05-17 | 2009-06-12 | Univ Cape Town | Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide, virus-like particles prepared therefrom and a method for preparing the particles |
-
2002
- 2002-12-09 GB GB0228715A patent/GB0228715D0/en not_active Ceased
-
2003
- 2003-12-05 AU AU2003290012A patent/AU2003290012A1/en not_active Abandoned
- 2003-12-05 WO PCT/EP2003/014040 patent/WO2004052395A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GB0228715D0 (en) | 2003-01-15 |
WO2004052395A1 (en) | 2004-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL163814A0 (en) | Virus-like particles of human papillomavirus | |
AU2003213606A1 (en) | MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU2003227533A1 (en) | Virus like particle from papillomavirus and their use in vaccine | |
AU2003272187A1 (en) | Novel nanoparticles and use thereof | |
AU2003248721A1 (en) | Adsorbents, methods of preparation, and methods of use thereof | |
AU2003298998A1 (en) | Oriented nanostructures and methods of preparing | |
AU2003293294A1 (en) | Uv-stabilised particles | |
AU2003279819A1 (en) | Shrimp and the production thereof | |
AU2003270626A1 (en) | Magnetically modified electrodes as well as methods of making and using the same | |
AU2003232650A1 (en) | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof | |
AU2003225756A1 (en) | Silica-based materials and methods | |
AU2003262804A1 (en) | Arginine silicate inositol complex and use thereof | |
AU2003231352A1 (en) | Biocidal formulation and methods for the preparation thereof | |
AU2003218099A1 (en) | Modulation of the immune response through the manipulation of arginine levels | |
AU2003290012A1 (en) | L2-peptide of the human papillomavirus associated with virus-like particles | |
AU2003296369A1 (en) | Imminoamines and preparation thereof | |
AU2003239610A1 (en) | Tiled biochips and the methods of making the same | |
AU2003285320A1 (en) | Vaccine | |
AU2003248879A1 (en) | RABS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU2003297612A1 (en) | 2-substituted-3-propenamide derivatives and methods of using the same | |
AU2003216546A1 (en) | Ultrasonic microkeratome | |
AU2003267361A1 (en) | Orthopoxvirus antigens and use thereof | |
GB0201382D0 (en) | Virus-like particles | |
GB0200258D0 (en) | Detection of human papillomavirus | |
AU2002236065A1 (en) | Papillomavirus vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |